Literature DB >> 12492619

Limited adherence to safety instructions in drug leaflets.

H J Derijks, G H P De Koning, A K Mantel-Teeuwisse, A C G Egberts.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12492619      PMCID： PMC1874487          DOI： 10.1046/j.1365-2125.2002.01701.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  Drug labeling revisions-guaranteed to fail?

Authors:  R L Woosley
Journal:  JAMA       Date:  2000-12-20       Impact factor: 56.272

2.  How many deaths are due to medical errors?

Authors:  P Honig; J Phillips; J Woodcock
Journal:  JAMA       Date:  2000-11-01       Impact factor: 56.272

3.  Learning from the cerivastatin experience.

Authors:  J A Farmer
Journal:  Lancet       Date:  2001-10-27       Impact factor: 79.321

Review 4.  FDA adverse event reports on statin-associated rhabdomyolysis.

Authors:  Mohamed A Omar; James P Wilson
Journal:  Ann Pharmacother       Date:  2002-02       Impact factor: 3.154

5.  Validation of pharmacy records in drug exposure assessment.

Authors:  H S Lau; A de Boer; K S Beuning; A Porsius
Journal:  J Clin Epidemiol       Date:  1997-05       Impact factor: 6.437
  5 in total
  1 in total

1.  Suboptimal choices and dosing of statins at start of therapy.

Authors:  Aukje K Mantel-Teeuwisse; Olaf H Klungel; Tom Schalekamp; W M Monique Verschuren; Arijan J Porsius; Anthonius de Boer
Journal:  Br J Clin Pharmacol       Date:  2005-07       Impact factor: 4.335
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.